BRCA2-RAD51

The use of fragment-based drug discovery to develop novel small molecules that modulate the BRCA2-RAD51 interaction for the treatment of cancer

CoordinatorTHE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Grant period2011-03-01 - 2013-02-28
Funding bodyEuropean Union
Call numberFP7-PEOPLE-2010-IIF
Grant number274569
IdentifierG:(EU-Grant)274569

     

Recent Publications

There are no publications


 Record created 2012-12-05, last modified 2023-03-01